Myotonic dystrophy (DM) is an inherited disease primarily affecting skeletal muscle. There are two forms of the disease: DM1 is caused by a CUG repeat expansion in the 3'untranslated region of the Dystrophia Myotonica Protein Kinase (DMPK) gene while DM2 results from a CCUG repeat expansion in an intron of the Zinc Finger Protein 9 (ZNF9) gene. Pathogenesis in both cases is caused principally by accumulation of toxic RNA species containing the expanded repeat. The mutant RNA sequesters Muscleblind, an RNA-binding protein important for processing of clinically relevant mRNAs. In addition, the mutant RNA induces aberrant expression of another RNA-binding protein, CUGBP1 through an unknown mechanism. This in turn impacts processing and decay of additional mRNAs. We will first examine how the toxic RNA species is metabolized by the cell with a view to eventually enhancing its removal. We will then move on to investigate the effects of CUGBP1 on two sets of mRNAs encoding proteins involved in myogenesis and in protein secretion. Finally, we will generate novel cell culture models from patient muscle cells and utilize them to discover changes in mRNA stability that occur in DM1. Overall, we hope to elucidate the fundamental molecular changes that occur in myotonic dystrophy and identify novel targets for future therapeutics.

Public Health Relevance

Myotonic dystrophy is a debilitating inherited disease primarily affecting skeletal muscle. The mutant gene produces a toxic RNA that impacts expression of other genes. Our research will determine the molecular mechanisms behind the toxicity of the mutant RNA and characterize the effects on expression of other clinically relevant genes. We hope to identify new avenues for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR059247-01A1
Application #
8041605
Study Section
Molecular Genetics B Study Section (MGB)
Program Officer
Nuckolls, Glen H
Project Start
2010-09-01
Project End
2015-05-31
Budget Start
2010-09-01
Budget End
2011-05-31
Support Year
1
Fiscal Year
2010
Total Cost
$302,778
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Microbiology/Immun/Virology
Type
Schools of Veterinary Medicine
DUNS #
785979618
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Russo, Joseph; Lee, Jerome E; López, Carolina M et al. (2017) The CELF1 RNA-Binding Protein Regulates Decay of Signal Recognition Particle mRNAs and Limits Secretion in Mouse Myoblasts. PLoS One 12:e0170680
Giovarelli, Matteo; Bucci, Gabriele; Ramos, Andres et al. (2014) H19 long noncoding RNA controls the mRNA decay promoting function of KSRP. Proc Natl Acad Sci U S A 111:E5023-8
Vlasova-St Louis, Irina; Dickson, Alexa M; Bohjanen, Paul R et al. (2013) CELFish ways to modulate mRNA decay. Biochim Biophys Acta 1829:695-707
Talwar, Sudha; Balasubramanian, Sundaravadivel; Sundaramurthy, Santhanalakshmi et al. (2013) Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells. RNA Biol 10:277-86
Wilusz, Carol J; Wilusz, Jeffrey (2013) Lsm proteins and Hfq: Life at the 3' end. RNA Biol 10:592-601
Lee, Jerome E; Lee, Ju Youn; Trembly, Jarrett et al. (2012) The PARN deadenylase targets a discrete set of mRNAs for decay and regulates cell motility in mouse myoblasts. PLoS Genet 8:e1002901
Wilusz, Carol J; Wilusz, Jeffrey (2010) Consequences of mRNA wardrobe malfunctions. Cell 143:863-5
Lee, Jerome E; Lee, Ju Youn; Wilusz, Jeffrey et al. (2010) Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One 5:e11201